 Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26
Dr Lal Path Labs Ltd reports Rs. 150.6 crores consolidated profit in Q2 FY26 Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores
Sammaan Capital Ltd consolidated Q2 FY2025-26 net profit at Rs. 308.47 crores Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores
Aptus Value Housing Finance India Ltd Q2 FY2026 consolidated PAT higher at Rs. 226.54 crores Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores
Sigma Solve Ltd Q2 FY2026 consolidated profit up at Rs. 6.64 crores Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores
Bajaj Electricals Ltd consolidated Q2FY26 PAT at Rs. 9.86 crores 
              The Nomination, Governance & Compensation committee of the Board of Directors of Dr. Reddy's Laboratories Ltd has allotted 18,739 equity shares of Rs.5/- each of the Company, fully paid up, on July 4, 2017, to Employees on exercise of their Stock Options.
16,710 equity shares of Rs. 5/- each were allotted pursuant to Dr. Reddy's Employees Stock Option Scheme, 2002 and 2,029 equity shares of Rs. 5/- each underlying 2,029 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007.
Shares of DR.REDDY'S LABORATORIES LTD. was last trading in BSE at Rs.2630.45 as compared to the previous close of Rs. 2680.85. The total number of shares traded during the day was 18566 in over 1573 trades.
The stock hit an intraday high of Rs. 2676.45 and intraday low of 2616. The net turnover during the day was Rs. 48993709.